US Stock MarketDetailed Quotes

Protalix Biotherapeutics (PLX)

Watchlist
  • 2.040
  • -0.020-0.97%
Close Jan 16 16:00 ET
  • 2.070
  • +0.030+1.47%
Post 18:03 ET
164.06MMarket Cap25.50P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Protalix Biotherapeutics (PLX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
-0.60%17.85M
16.21%15.66M
169.82%10.11M
-18.47%53.4M
73.74%18.22M
73.60%17.96M
-61.59%13.47M
-60.91%3.75M
37.48%65.49M
21.69%10.49M
Operating revenue
-0.60%17.85M
16.21%15.66M
169.82%10.11M
-18.47%53.4M
73.74%18.22M
73.60%17.96M
-61.59%13.47M
-60.91%3.75M
37.48%65.49M
21.69%10.49M
Cost of revenue
-0.61%8.32M
-37.92%5.87M
214.37%8.18M
5.82%24.32M
-56.12%3.89M
71.16%8.38M
53.81%9.46M
-15.66%2.6M
17.30%22.98M
269.46%8.86M
Gross profit
-0.59%9.53M
143.60%9.79M
68.67%1.93M
-31.60%29.08M
779.26%14.33M
75.79%9.58M
-86.11%4.02M
-82.38%1.15M
51.58%42.51M
-73.79%1.63M
Operating expense
32.24%7.4M
33.69%8.62M
1.27%6.08M
-21.49%25.16M
-1.68%7.12M
-23.79%5.59M
-24.23%6.45M
-33.03%6M
-21.94%32.05M
-16.87%7.25M
Selling and administrative expenses
12.87%2.93M
-24.68%2.62M
-16.44%2.6M
-18.49%12.19M
-27.61%3M
-29.29%2.6M
-13.57%3.48M
0.00%3.12M
27.73%14.96M
33.73%4.14M
Research and development costs
49.00%4.47M
102.36%5.99M
20.37%3.48M
-24.12%12.97M
32.95%4.12M
-18.29%3M
-33.83%2.96M
-50.62%2.89M
-41.76%17.09M
-44.77%3.1M
Operating profit
-46.60%2.13M
148.29%1.17M
14.64%-4.15M
-62.55%3.92M
228.39%7.21M
311.50%3.99M
-111.88%-2.43M
-97.48%-4.86M
180.37%10.46M
-125.05%-5.62M
Net non-operating interest income expense
172.97%108K
-429.68%-511K
235.77%413K
112.51%237K
113.19%107K
-188.10%-148K
120.03%155K
125.79%123K
-36.95%-1.89M
-13.43%-811K
Non-operating interest income
90.73%288K
-47.89%272K
-18.32%419K
1.01%1.3M
405.41%113K
-75.96%151K
-1.69%522K
198.26%513K
12.22%1.29M
43.08%-37K
Non-operating interest expense
-39.80%180K
113.35%783K
-98.46%6K
-66.60%1.06M
-99.22%6K
-35.00%299K
-71.88%367K
-39.91%390K
25.74%3.18M
19.08%774K
Other net income (expense)
Income before tax
-41.74%2.24M
129.09%661K
21.15%-3.73M
-51.51%4.15M
213.85%7.32M
323.56%3.84M
-111.56%-2.27M
-61.21%-4.73M
159.50%8.57M
-100.19%-6.43M
Income tax
-119.11%-116K
820.29%497K
18.12%-113K
381.10%1.22M
315.18%822K
356.39%607K
-122.40%-69K
-170.77%-138K
-52.08%254K
-172.08%-382K
Net income
-27.22%2.36M
107.44%164K
21.24%-3.62M
-64.73%2.93M
207.45%6.49M
274.73%3.24M
-111.39%-2.2M
-46.76%-4.6M
155.68%8.31M
-61.60%-6.04M
Net income continuous Operations
-27.22%2.36M
107.44%164K
21.24%-3.62M
-64.73%2.93M
207.45%6.49M
274.73%3.24M
-111.39%-2.2M
-46.76%-4.6M
155.68%8.31M
-61.60%-6.04M
Minority interest income
Net income attributable to the parent company
-27.22%2.36M
107.44%164K
21.24%-3.62M
-64.73%2.93M
207.45%6.49M
274.73%3.24M
-111.39%-2.2M
-46.76%-4.6M
155.68%8.31M
-61.60%-6.04M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-27.22%2.36M
107.44%164K
21.24%-3.62M
-64.73%2.93M
207.45%6.49M
274.73%3.24M
-111.39%-2.2M
-46.76%-4.6M
155.68%8.31M
-61.60%-6.04M
Basic earnings per share
-25.00%0.03
0
16.67%-0.05
-66.67%0.04
190.00%0.09
233.33%0.04
-110.34%-0.03
-20.00%-0.06
138.71%0.12
-42.86%-0.1
Diluted earnings per share
0.00%0.03
0
16.67%-0.05
-55.56%0.04
190.00%0.09
175.00%0.03
-114.29%-0.03
-20.00%-0.06
129.03%0.09
-42.86%-0.1
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue -0.60%17.85M16.21%15.66M169.82%10.11M-18.47%53.4M73.74%18.22M73.60%17.96M-61.59%13.47M-60.91%3.75M37.48%65.49M21.69%10.49M
Operating revenue -0.60%17.85M16.21%15.66M169.82%10.11M-18.47%53.4M73.74%18.22M73.60%17.96M-61.59%13.47M-60.91%3.75M37.48%65.49M21.69%10.49M
Cost of revenue -0.61%8.32M-37.92%5.87M214.37%8.18M5.82%24.32M-56.12%3.89M71.16%8.38M53.81%9.46M-15.66%2.6M17.30%22.98M269.46%8.86M
Gross profit -0.59%9.53M143.60%9.79M68.67%1.93M-31.60%29.08M779.26%14.33M75.79%9.58M-86.11%4.02M-82.38%1.15M51.58%42.51M-73.79%1.63M
Operating expense 32.24%7.4M33.69%8.62M1.27%6.08M-21.49%25.16M-1.68%7.12M-23.79%5.59M-24.23%6.45M-33.03%6M-21.94%32.05M-16.87%7.25M
Selling and administrative expenses 12.87%2.93M-24.68%2.62M-16.44%2.6M-18.49%12.19M-27.61%3M-29.29%2.6M-13.57%3.48M0.00%3.12M27.73%14.96M33.73%4.14M
Research and development costs 49.00%4.47M102.36%5.99M20.37%3.48M-24.12%12.97M32.95%4.12M-18.29%3M-33.83%2.96M-50.62%2.89M-41.76%17.09M-44.77%3.1M
Operating profit -46.60%2.13M148.29%1.17M14.64%-4.15M-62.55%3.92M228.39%7.21M311.50%3.99M-111.88%-2.43M-97.48%-4.86M180.37%10.46M-125.05%-5.62M
Net non-operating interest income expense 172.97%108K-429.68%-511K235.77%413K112.51%237K113.19%107K-188.10%-148K120.03%155K125.79%123K-36.95%-1.89M-13.43%-811K
Non-operating interest income 90.73%288K-47.89%272K-18.32%419K1.01%1.3M405.41%113K-75.96%151K-1.69%522K198.26%513K12.22%1.29M43.08%-37K
Non-operating interest expense -39.80%180K113.35%783K-98.46%6K-66.60%1.06M-99.22%6K-35.00%299K-71.88%367K-39.91%390K25.74%3.18M19.08%774K
Other net income (expense)
Income before tax -41.74%2.24M129.09%661K21.15%-3.73M-51.51%4.15M213.85%7.32M323.56%3.84M-111.56%-2.27M-61.21%-4.73M159.50%8.57M-100.19%-6.43M
Income tax -119.11%-116K820.29%497K18.12%-113K381.10%1.22M315.18%822K356.39%607K-122.40%-69K-170.77%-138K-52.08%254K-172.08%-382K
Net income -27.22%2.36M107.44%164K21.24%-3.62M-64.73%2.93M207.45%6.49M274.73%3.24M-111.39%-2.2M-46.76%-4.6M155.68%8.31M-61.60%-6.04M
Net income continuous Operations -27.22%2.36M107.44%164K21.24%-3.62M-64.73%2.93M207.45%6.49M274.73%3.24M-111.39%-2.2M-46.76%-4.6M155.68%8.31M-61.60%-6.04M
Minority interest income
Net income attributable to the parent company -27.22%2.36M107.44%164K21.24%-3.62M-64.73%2.93M207.45%6.49M274.73%3.24M-111.39%-2.2M-46.76%-4.6M155.68%8.31M-61.60%-6.04M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -27.22%2.36M107.44%164K21.24%-3.62M-64.73%2.93M207.45%6.49M274.73%3.24M-111.39%-2.2M-46.76%-4.6M155.68%8.31M-61.60%-6.04M
Basic earnings per share -25.00%0.03016.67%-0.05-66.67%0.04190.00%0.09233.33%0.04-110.34%-0.03-20.00%-0.06138.71%0.12-42.86%-0.1
Diluted earnings per share 0.00%0.03016.67%-0.05-55.56%0.04190.00%0.09175.00%0.03-114.29%-0.03-20.00%-0.06129.03%0.09-42.86%-0.1
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.11%
Sample Name
Sample Code
 +2.53%
Sample Name
Sample Code
 +2.08%
4
Tempus AI
TEM
+2.05%
5
Block
XYZ
+1.59%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.35%
Sample Name
Sample Code
 +10.03%
Sample Name
Sample Code
 +9.57%
4
Kingsoft Cloud
KC
+7.99%
5
United Microelectronics
UMC
+5.80%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -